Kyowa Kirin Co. Ltd.
KYKOF | OTC
$15.80
+$0.30 (+1.94%)
At close: Oct 30, 2026, 3:59 PM ET
$16.75
+$0.95 (+6.03%)
After-hours:
Oct 30, 2026, 4:00 PM ET
+1.94%
(1D)No price chart data available for 1D timeframe.
Rating
70.2
-1.8 ptsFundamentals Excellent
Market Sentiment Neutral
Moat Narrow
Sector Rank #58/1028 (Top 6%)
Key Statistics
Market Data
Market Cap $8.27B
1D Range
15.80 15.80
52W Range
12.42 18.00
Valuation (TTM)
PE 15.68
PB 1.47
EV/EBITDA 7.12
Valuation (NTM)
Forward PE 13.33
Forward PEG 0.34
Price Target N/A
Cash Flow
FCF Yield 7.9%
SBC Adj. FCF Yield 7.9%
SBC Impact N/A
Margins
Gross Margin 73.9%
Operating Margin 24.4%
FCF Margin 19.4%
Growth (CAGR)
Revenue 3Y | 5Y 8.7% |
10.2%
Dil EPS 3Y | 5Y 27.6% |
13.5%
FCF 3Y | 5Y 16.1% |
24.1%
Returns
ROA 7.2%
ROE 9.2%
ROIC 10.8%
Financial Health
Net Cash
¥265.08B ($1.63B)
Current Ratio 2.84
Interest Coverage 39.95
Dividends
Div Yield 2.66%
Payout Ratio 0.3%
FCF Payout Ratio 31.6%
Loading financial charts...
Profile
Kyowa Kirin Co., Ltd. is a global pharmaceutical company engaged in the development, manufacturing, and commercialization of medicines, with a primary focus on therapeutic areas including oncology, ne...
Sector Healthcare
Industry Medical - Pharmaceuticals
Employees 5,161
IPO Date Aug 17, 2012
Website www.kyowakirin.co.jp
Fiscal Year n/a
Latest News
No news articles available yet.
Earnings
Latest Earnings
Nov 2, 2026
EPS
$0.26
Beat +1.83%
YoY:
+21.65% REV
$771.2M
Miss -3.17%
YoY:
-3.97%Next Earnings
Feb 10, 2027
EPS Est
Pro
Rev Est
Pro
Add to Watchlist
Select watchlists to add or remove KYKOF